Abdullah Demirtaş1, Esma Eren2, Gökhan Sönmez3, Şevket Tolga Tombul1, Emine Alp4. 1. Department of Urology, Erciyes University School of Medicine, Kayseri, Turkey. 2. Department of Infectious Diseases and Clinical Microbiology, Kayseri City Hospital, Kayseri, Turkey. 3. Department of Urology, Kayseri City Hospital, Kayseri, Turkey. 4. Department of Infectious Diseases and Clinical Microbiology, Erciyes University School of Medicine, Kayseri, Turkey.
Abstract
OBJECTIVE: Antibiotic prophylaxis for transrectal prostate biopsy (PB) is very important in preventing infectious complications, and in this study, we aimed to evaluate the antibiotic preferences of Turkish urologist for transrectal PB. MATERIAL AND METHODS: The survey about PB and antibiotic prophylaxis behaviors was administered to urologists working in Turkey who had previously participated in at least one international and one national congress. RESULTS: A total of 237 urologists were included in the study. Antibiotic prophylaxis prior to PB was performed by 234 (98.7%) participants. Rectal swabbing prior to PB was not performed by 227 (95.8%) participants. The most common complication associated with PB was prostatitis (63%), followed by urinary tract infection (29%). Only 25.7% of Turkish urologists reported a single dose of antibiotic prophylaxis. Our participants often administered antibiotic prophylaxis for a period of 3, 5, or 7 days (16%, 21.1%, 35.9%, respectively). The most common antibiotic agent preferred for prophylaxis was ciprofloxacin (65%). CONCLUSION: The biopsy behavior of Turkish urologists was mostly compatible with the literature, but it was revealed that Turkish urologists do not prefer single-dose antibiotic therapy, and their practice patterns regarding the administration of pre-biopsy rectal swabbing are inconsistent with the literature.
OBJECTIVE: Antibiotic prophylaxis for transrectal prostate biopsy (PB) is very important in preventing infectious complications, and in this study, we aimed to evaluate the antibiotic preferences of Turkish urologist for transrectal PB. MATERIAL AND METHODS: The survey about PB and antibiotic prophylaxis behaviors was administered to urologists working in Turkey who had previously participated in at least one international and one national congress. RESULTS: A total of 237 urologists were included in the study. Antibiotic prophylaxis prior to PB was performed by 234 (98.7%) participants. Rectal swabbing prior to PB was not performed by 227 (95.8%) participants. The most common complication associated with PB was prostatitis (63%), followed by urinary tract infection (29%). Only 25.7% of Turkish urologists reported a single dose of antibiotic prophylaxis. Our participants often administered antibiotic prophylaxis for a period of 3, 5, or 7 days (16%, 21.1%, 35.9%, respectively). The most common antibiotic agent preferred for prophylaxis was ciprofloxacin (65%). CONCLUSION: The biopsy behavior of Turkish urologists was mostly compatible with the literature, but it was revealed that Turkish urologists do not prefer single-dose antibiotic therapy, and their practice patterns regarding the administration of pre-biopsy rectal swabbing are inconsistent with the literature.
Authors: Franck Bruyère; Sandra Malavaud; Philippe Bertrand; Aliette Decock; Gérard Cariou; Jean Dominique Doublet; Louis Bernard; Hubert Bugel; Sophie Conquy; Albert Sotto; Jean Paul Boiteux; Bertrand Pogu; Xavier Rebillard; Pierre Mongiat-Artus; Patrick Coloby Journal: J Urol Date: 2014-07-22 Impact factor: 7.450
Authors: Lana Pepdjonovic; Guan Hee Tan; Sean Huang; Sarah Mann; Mark Frydenberg; Daniel Moon; Uri Hanegbi; Adam Landau; Ross Snow; Jeremy Grummet Journal: World J Urol Date: 2016-12-16 Impact factor: 4.226